Current Value of Holding

$14.4 Million

Shares

2.07 Million

% of Portfolio

0.01%

Average Buy Price

$14.4

Avg closing price
Price range

16 PRIMECAP Management Health Catalyst Trades

PRIMECAP Management's position in Health Catalyst is currently worth $14.4 Million. That's 0.01% of their equity portfolio (239th largest holding). The investor owns 3.47% of the outstanding Health Catalyst stock. The first Health Catalyst trade was made in Q2 2020. Since then PRIMECAP Management bought shares thirteen more times and sold shares on two occasions. The investor's estimated purchase price is $30 Million, resulting in a loss of 52%.

Avg closing price
Price range
Increased shares by 46.1% (+655 Thousand shares) Q1 2024
Avg closing price $9.13
Price range $7.44 - $11.21
Increased shares by 26.7% (+299 Thousand shares) Q4 2023
Avg closing price $8.17
Price range $6.71 - $10.16
Increased shares by 86.3% (+519 Thousand shares) Q3 2023
Avg closing price $11.94
Price range $9.35 - $14.32
Increased shares by 1.9% (+11.1 Thousand shares) Q2 2023
Avg closing price $11.91
Price range $9.86 - $13.12
Increased shares by 25.2% (+119 Thousand shares) Q1 2023
Avg closing price $12.75
Price range $10.23 - $14.76
Sold 0.2% shares (-910 shares) Q4 2022
Avg closing price $9.65
Price range $6.47 - $11.32
Increased shares by 54.2% (+166 Thousand shares) Q3 2022
Avg closing price $13.24
Price range $9.30 - $18.27
Increased shares by 12.8% (+34.7 Thousand shares) Q2 2022
Avg closing price $17.05
Price range $11.79 - $27.63
Increased shares by 13.0% (+31.3 Thousand shares) Q1 2022
Avg closing price $28.37
Price range $20.67 - $40.33
Increased shares by 3.1% (+7.34 Thousand shares) Q4 2021
Avg closing price $45.57
Price range $36.68 - $54.02
Sold 0.0% shares (-106 shares) Q3 2021
Avg closing price $54.54
Price range $49.57 - $58.15
Increased shares by 5.0% (+11 Thousand shares) Q2 2021
Avg closing price $53.27
Price range $47.17 - $58.64
Increased shares by 120.0% (+121 Thousand shares) Q1 2021
Avg closing price $48.44
Price range $42.51 - $54.07
Increased shares by 55.5% (+36 Thousand shares) Q4 2020
Avg closing price $36.89
Price range $31.90 - $44.89
Increased shares by 44.5% (+20 Thousand shares) Q3 2020
Avg closing price $33.96
Price range $28.55 - $36.91
New holding (+44.9 Thousand shares) Q2 2020
Avg closing price $27.63
Price range $24.00 - $32.87

News about Health Catalyst Inc and PRIMECAP Management

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!